BARUTTA, Federica
 Distribuzione geografica
Continente #
NA - Nord America 5.492
EU - Europa 3.339
AS - Asia 1.676
SA - Sud America 151
AF - Africa 68
OC - Oceania 34
Continente sconosciuto - Info sul continente non disponibili 5
Totale 10.765
Nazione #
US - Stati Uniti d'America 5.306
DK - Danimarca 1.181
CN - Cina 1.037
IT - Italia 614
DE - Germania 252
IE - Irlanda 245
FR - Francia 180
AT - Austria 150
SE - Svezia 133
IN - India 113
CA - Canada 109
GB - Regno Unito 105
FI - Finlandia 103
JP - Giappone 94
VN - Vietnam 86
UA - Ucraina 75
PL - Polonia 69
KR - Corea 68
MX - Messico 59
ES - Italia 56
BR - Brasile 44
TR - Turchia 44
GR - Grecia 37
HK - Hong Kong 36
CO - Colombia 31
AU - Australia 30
TW - Taiwan 28
SG - Singapore 24
BE - Belgio 23
ID - Indonesia 23
AR - Argentina 22
IQ - Iraq 22
NL - Olanda 22
TH - Thailandia 22
CH - Svizzera 20
EG - Egitto 20
PE - Perù 19
CL - Cile 17
SN - Senegal 13
AE - Emirati Arabi Uniti 12
AL - Albania 10
PT - Portogallo 10
RO - Romania 10
RU - Federazione Russa 10
SA - Arabia Saudita 10
PK - Pakistan 9
KZ - Kazakistan 8
BO - Bolivia 7
BY - Bielorussia 7
IR - Iran 7
TN - Tunisia 7
IL - Israele 6
NO - Norvegia 6
PH - Filippine 6
RS - Serbia 6
DZ - Algeria 5
EC - Ecuador 4
EU - Europa 4
GT - Guatemala 4
MY - Malesia 4
NG - Nigeria 4
NP - Nepal 4
NZ - Nuova Zelanda 4
PR - Porto Rico 4
BG - Bulgaria 3
HR - Croazia 3
KE - Kenya 3
MA - Marocco 3
PA - Panama 3
UG - Uganda 3
VE - Venezuela 3
BJ - Benin 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
GH - Ghana 2
HU - Ungheria 2
JO - Giordania 2
LI - Liechtenstein 2
MG - Madagascar 2
MO - Macao, regione amministrativa speciale della Cina 2
PY - Paraguay 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
YE - Yemen 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BN - Brunei Darussalam 1
BT - Bhutan 1
CM - Camerun 1
CZ - Repubblica Ceca 1
EE - Estonia 1
ET - Etiopia 1
KW - Kuwait 1
LB - Libano 1
LK - Sri Lanka 1
MC - Monaco 1
MK - Macedonia 1
NI - Nicaragua 1
PS - Palestinian Territory 1
SI - Slovenia 1
SO - Somalia 1
Totale 10.763
Città #
Ann Arbor 1.856
Chandler 395
Beijing 351
Houston 279
Fairfield 253
Dublin 245
Wilmington 208
Torino 200
Ashburn 199
Woodbridge 175
Vienna 145
Seattle 114
Dearborn 109
Nyköping 91
Princeton 86
Cambridge 85
Villeurbanne 82
Medford 81
Redwood City 81
Fremont 72
Jacksonville 72
Shanghai 68
Pisa 63
Turin 58
Warsaw 57
Guangzhou 55
Dong Ket 52
Munich 43
Montréal 38
Palaiseau 36
Boston 33
Nanjing 33
San Diego 33
Milan 31
Grafing 28
Hangzhou 27
Hefei 26
Toronto 26
Changsha 24
Chengdu 23
Taipei 23
Tokyo 23
London 22
Athens 19
Ottawa 19
Baghdad 18
Chongqing 18
Helsinki 18
Wuhan 18
Zhengzhou 18
Mountain View 17
Shenyang 16
Los Angeles 15
Phoenix 15
Des Moines 14
Jinan 14
Nanchang 14
Lima 13
Moncalieri 13
Singapore 13
Washington 13
Falls Church 12
Harbin 12
Hebei 12
Napoli 12
São Paulo 12
Verona 12
Bogotá 11
Brussels 11
Hamburg 11
Shenzhen 11
Central District 10
Copenhagen 10
Düsseldorf 10
Jakarta 10
Kunming 10
Menlo Park 10
Tianjin 10
Xian 10
Chennai 9
Delhi 9
Mexico City 9
Seoul 9
Sharjah 9
Tirana 9
Edinburgh 8
Fuzhou 8
Hong Kong 8
New Delhi 8
New York 8
Norwalk 8
Silver Spring 8
Tong 8
Zurich 8
Bengaluru 7
Buffalo 7
Central 7
Changchun 7
Guiyang 7
Istanbul 7
Totale 6.650
Nome #
Novel biomarkers of diabetic kidney disease: current status and potential clinical application 1.042
Inflammation in diabetic nephropathy: moving toward clinical biomarkers and targets for treatment 735
Deficiency of cannabinoid receptor of type 2 worsens renal functional and structural abnormalities in streptozotocin-induced diabetic mice 508
Diabetes-specific variables associated with quality of life changes in young diabetic people: the type 1 diabetes Registry of Turin (Italy) 344
Hippocampal heat shock protein 25 expression in streptozotocin-induced diabetic mice. 281
Urinary Exosomal MicroRNAs in Incipient Diabetic Nephropathy 277
SGLT2 inhibition to address the unmet needs in diabetic nephropathy 236
Circulating anti-Hsp70 levels in nascent metabolic syndrome: the Casale Monferrato Study. 223
NT-proBNP Linking Low-Moderately Impaired Renal Function and Cardiovascular Mortality in Diabetic Patients: The Population-Based Casale Monferrato Study 223
The Effect of Age and NT-proBNP on the Association of Central Obesity with 6-Years Cardiovascular Mortality of Middle-Aged and Elderly Diabetic People: The Population-Based Casale Monferrato Study 217
Serum levels of heat shock protein 27 in patients with acute ischemic stroke 209
What is the impact of sleeve gastrectomy and gastric bypass on metabolic control of diabetes? A clinic-based cohort of Mediterranean diabetic patients 194
Urinary exosomal microRNA signature in incipient diabetic nephropathy 187
Anti-HSP70 levels and the metabolic syndrome: the Casale Monferrato Study 185
Associazione tra anti-HSP70 e sindrome plurimetabolica: il Casale Monferrato Study 182
N-terminal probrain natriuretic peptide is a stronger predictor of cardiovascular mortality than C-reactive protein and albumin excretion rate in elderly patients with type 2 diabetes: the Casale Monferrato population-based study. 182
Levels of N-terminal pro brain natriuretic peptide are enhanced in people with the uncomplicated metabolic syndrome: a nested case-control analysis of the population-based Casale Monferrato Study 179
Ruolo protettivo del recettore CB2 nella nefropatia diabetica sperimentale 175
Cannabinoid receptor 1 blockade ameliorates albuminuria in experimental diabetic nephropathy 174
Protective role of cannabinoid receptor type-2 in a mouse model of diabetic nephropathy 172
Early life socioeconomic indicators and the risk of type 1 diabetes in children and young adults 169
Role of the endocannabinoid system in diabetes and diabetic complications 167
Effect of the MCP-1/CCR2 system on nephrin expression in streptozotocin-treated mice and human cultured podocytes 165
Retinal heat shock protein 25 in early experimental diabetes 164
Uric acid is not an independent predictor of cardiovascular mortality in type 2 diabetes: a population-based study 163
ATTIVAZIONE DEL RECETTORE CB2 E NEFROPATIA DIABETICA SPERIMENTALE 161
Increased QT interval dispersion predicts 15-years cardiovascular mortality in type 2 diabetic subjects. The population-based Casale Monferrato Study 160
Effect of CB2 receptor deletion in streptozotocin-induced diabetic mice 157
The Monocyte Chemoattractant Protein-1/Cognate CC Chemokine Receptor 2 System Affects Cell Motility in Cultured Human Podocytes 156
Effect of CB2 Receptor Activation in Experimental Diabetic Nephropathy 154
Diabetic kidney disease: New clinical and therapeutic issues. Joint position statement of the Italian Diabetes Society and the Italian Society of Nephrology on “The natural history of diabetic kidney disease and treatment of hyperglycemia in patients with type 2 diabetes and impaired renal function” 153
NH2-Terminal Probrain Natriuretic Peptide Is Associated With Diabetes Complications in the EURODIAB Prospective Complications Study: The role of tumor necrosis factor-α 152
Effects of CB1 Blockade In Experimental Diabetic Nephropathy 151
Heat shock protein expression in early diabetic nephropathy 151
Obesity is associated with lower mortality risk in elderly diabetic subjects: the Casale Monferrato study. 150
Espressione delle Heat Shock Proteins nella nefropatia diabetica sperimentale 150
Mechanical stretch and angiotensin II activate Janus tyrosine kinase-2 in human podocytes 150
Severe Hypoglycemia and Cardiovascular Disease Incidence in Type 1 Diabetes: The EURODIAB Prospective Complications Study. 149
QTc Interval Prolongation Is Independently Associated With Severe Hypoglycemic Attacks in Type 1 Diabetes From the EURODIAB IDDM Complications Study 148
Heat shock protein expression in diabetic nephropathy 145
Incidence of prolonged QTc and severe hypoglycemia in type 1 diabetes: the EURODIAB Prospective Complications Study 142
Mechanical stretch induces fibronectin production in human podocytes via a TGF-beta 1-dependent mechanism 136
Response to Comment on: Gruden et al. Severe Hypoglycemia and Cardiovascular Disease Incidence in Type 1 Diabetes: The EURODIAB Prospective Complications Study. Diabetes Care 2012;35:1598-1604. 134
Short term variation in NTproBNP after lifestyle intervention in severe obesity. 125
MicroRNA-126 and micro-/macrovascular complications of type 1 diabetes in the EURODIAB Prospective Complications Study 110
Self-management education may improve blood pressure in people with type 2diabetes. A randomized controlled clinical trial. 109
Co-activator-associated arginine methyltransferase 1 (CARM1) is overexpressed in type 2 diabetes. 104
The future of diabetic kidney disease management: what to expect from the experimental studies? 87
Serum levels of anti-heat shock protein 27 antibodies in patients with chronic liver disease 84
Dual therapy targeting the endocannabinoid system prevents experimental diabetic nephropathy 83
MicroRNA and microvascular complications of diabetes 81
Heat Shock Proteins in Vascular Diabetic Complications: Review and Future Perspective 80
Protective effect of the tunneling nanotube-TNFAIP2/M-sec system on podocyte autophagy in diabetic nephropathy 72
Deletion of RAGE fails to prevent hepatosteatosis in obese mice due to impairment of other AGEs receptors and detoxifying systems 71
The co-activator-associated arginine methyltransferase 1 (CARM1) gene is overexpressed in type 2 diabetes. 66
Targeting the MCP-1/CCR2 System in diabetic kidney disease 64
Cannabinoid Receptors in Diabetic Kidney Disease 61
Protective Role of the M-Sec-Tunneling Nanotube System in Podocytes 61
Extra-Esophageal Presentation of Gastroesophageal Reflux Disease: 2020 Update 57
Genetic deletion of RAGE in db/db mice interferes in the liver with other AGE-receptors and AGE-detoxifying systems sustaining lipogenesis and inflammation 50
Treatment with eltrombopag of severe immune thrombocytopenia and hemolytic anemia associated with COVID-19 pneumonia: a case report 49
Reduced thiamine availability and hyperglycemia impair thiamine transport in renal glomerular cells through modulation of thiamine transporter 2 47
Mechanisms of podocyte injury and implications for diabetic nephropathy 43
Diabetic kidney disease: new clinical and therapeutic issues. Joint position statement of the Italian Diabetes Society and the Italian Society of Nephrology on “The natural history of diabetic kidney disease and treatment of hyperglycemia in patients with type 2 diabetes and impaired renal function” 41
Reversal of albuminuria by combined AM6545 and perindopril therapy in experimental diabetic nephropathy 37
The role of cannabinoid signaling in acute and chronic kidney diseases 34
Novel Insight into the Mechanisms of the Bidirectional Relationship between Diabetes and Periodontitis 34
MicroRNA 146a is associated with diabetic complications in type 1 diabetic patients from the EURODIAB PCS 28
Association of serum MicroRNA-145-5p levels with microvascular complications of type 1 Diabetes: The EURODIAB prospective complications study 20
Indications for renal biopsy in patients with diabetes. Joint position statement of the Italian Society of Nephrology and the Italian Diabetes Society 20
Genetic deletion of RAGE in Dbdb mice interferes with AGEs receptors and detoxifying systems in liver 6
Serum MicroRNA-191-5p Levels in Vascular Complications of Type 1 Diabetes: the EURODIAB Prospective Complications Study 2
Totale 11.178
Categoria #
all - tutte 23.238
article - articoli 0
book - libri 0
conference - conferenze 3.728
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.966


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019265 0 0 0 0 0 0 0 0 0 0 159 106
2019/20202.376 72 59 207 173 283 466 161 90 101 171 284 309
2020/20211.155 226 42 54 64 67 56 76 45 88 75 64 298
2021/20222.660 256 222 236 284 229 225 255 261 220 94 199 179
2022/20231.766 188 94 57 124 162 366 161 155 163 57 147 92
2023/2024966 133 139 90 79 104 103 60 125 28 101 4 0
Totale 11.178